Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
Crossref DOI link: https://doi.org/10.1007/s40119-021-00233-7
Published Online: 2021-07-12
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Angeli, Fabio http://orcid.org/0000-0003-4925-7985
Verdecchia, Paolo
Reboldi, Gianpaolo
Text and Data Mining valid from 2021-07-12
Version of Record valid from 2021-07-12
Article History
Received: 26 May 2021
First Online: 12 July 2021